X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (42670) 42670
Publication (3199) 3199
Book Review (547) 547
Book Chapter (318) 318
Book / eBook (277) 277
Newsletter (76) 76
Conference Proceeding (72) 72
Dissertation (28) 28
Magazine Article (26) 26
Data Set (11) 11
Newspaper Article (3) 3
Paper (3) 3
Reference (3) 3
Trade Publication Article (3) 3
Web Resource (3) 3
Transcript (2) 2
Government Document (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32984) 32984
male (24648) 24648
female (20510) 20510
index medicus (18280) 18280
middle aged (15604) 15604
clinical neurology (14220) 14220
aged (14055) 14055
stroke (12818) 12818
adult (10632) 10632
neurosciences (9318) 9318
risk factors (7032) 7032
animals (6954) 6954
magnetic resonance imaging (6608) 6608
surgery (6558) 6558
neurology (5519) 5519
treatment outcome (5315) 5315
aged, 80 and over (5041) 5041
brain (4935) 4935
tomography, x-ray computed (4919) 4919
cerebral infarction (4885) 4885
ischemia (4563) 4563
peripheral vascular disease (4414) 4414
cerebral infarction - etiology (4402) 4402
cerebral infarction - complications (4359) 4359
retrospective studies (3974) 3974
rats (3796) 3796
cerebral angiography (3538) 3538
time factors (3338) 3338
brain - pathology (3134) 3134
medicine & public health (3037) 3037
adolescent (3036) 3036
stroke - etiology (2899) 2899
care and treatment (2890) 2890
prognosis (2787) 2787
mortality (2785) 2785
infarction (2770) 2770
brain ischemia - complications (2768) 2768
disease models, animal (2659) 2659
follow-up studies (2643) 2643
analysis (2557) 2557
cerebral ischemia (2425) 2425
research (2414) 2414
subarachnoid hemorrhage (2409) 2409
child (2391) 2391
prospective studies (2387) 2387
risk (2377) 2377
stroke - complications (2309) 2309
neurosurgery (2298) 2298
diagnosis (2270) 2270
cerebral infarction - diagnosis (2268) 2268
health aspects (2213) 2213
hemorrhage (2144) 2144
radiology, nuclear medicine & medical imaging (2101) 2101
cerebral infarction - pathology (2054) 2054
neuroimaging (2044) 2044
pediatrics (2034) 2034
patients (1984) 1984
disease (1926) 1926
management (1820) 1820
hypertension (1817) 1817
cardiovascular diseases (1800) 1800
infarction, middle cerebral artery - complications (1786) 1786
cardiac & cardiovascular systems (1765) 1765
brain ischemia - etiology (1754) 1754
aneurysms (1738) 1738
rats, sprague-dawley (1735) 1735
complications and side effects (1709) 1709
complications (1693) 1693
risk-factors (1686) 1686
cerebral infarction - diagnostic imaging (1682) 1682
severity of illness index (1675) 1675
therapy (1629) 1629
cerebral hemorrhage - etiology (1607) 1607
acute ischemic-stroke (1605) 1605
mice (1598) 1598
medicine, general & internal (1589) 1589
child, preschool (1567) 1567
ischemic stroke (1566) 1566
intracerebral hemorrhage (1536) 1536
cerebrovascular circulation (1535) 1535
article (1521) 1521
cerebral hemorrhage - complications (1486) 1486
medicine (1459) 1459
young adult (1452) 1452
focal cerebral-ischemia (1448) 1448
brain ischemia - pathology (1443) 1443
infant, newborn (1442) 1442
cerebral blood flow (1432) 1432
acute disease (1426) 1426
magnetic resonance angiography (1416) 1416
medical research (1414) 1414
neuroprotection (1378) 1378
cerebral-ischemia (1372) 1372
ischemic-stroke (1358) 1358
inflammation (1354) 1354
stroke - physiopathology (1353) 1353
medical imaging (1349) 1349
stroke - pathology (1344) 1344
children (1342) 1342
diagnosis, differential (1341) 1341
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (218) 218
UTL at Downsview - May be requested (11) 11
Holland Bloorview Kids Rehabilitation - Stacks (10) 10
OISE - Stacks (10) 10
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
UofT at Mississauga - Stacks (9) 9
Online Resources - Online (7) 7
Baycrest Hospital - Stacks (6) 6
West Park Healthcare Centre - Stacks (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
St. Michael's Hospital - Stacks (3) 3
Providence Healthcare - Reference (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
West Park Healthcare Centre - Hospital Department (2) 2
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Periodical Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
OISE - Lost (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (39668) 39668
Japanese (1229) 1229
French (557) 557
German (535) 535
Spanish (521) 521
Chinese (220) 220
Russian (197) 197
Polish (71) 71
Dutch (51) 51
Italian (50) 50
Portuguese (49) 49
Norwegian (33) 33
Danish (22) 22
Korean (18) 18
Finnish (16) 16
Hungarian (13) 13
Swedish (12) 12
Serbian (9) 9
Czech (8) 8
Croatian (6) 6
Romanian (5) 5
Hebrew (4) 4
Turkish (4) 4
Lithuanian (3) 3
Bosnian (2) 2
Slovak (2) 2
Arabic (1) 1
Bulgarian (1) 1
Icelandic (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 1, pp. 11 - 21
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1287 - 1296
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 25, pp. 2419 - 2432
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 23, pp. 2247 - 2257
In this randomized study, the addition of lixisenatide, a glucagon-like peptide 1–receptor agonist, to usual care in patients with type 2 diabetes and a recent... 
MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | GLUCAGON-LIKE PEPTIDE-1 | MYOCARDIAL-INFARCTION | CARDIOVASCULAR OUTCOMES | RECEPTOR AGONISTS | GLUCOSE | DOUBLE-BLIND | FOLLOW-UP | MELLITUS | CONGESTIVE-HEART-FAILURE | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - complications | Acute Coronary Syndrome - complications | Angina, Unstable - complications | Diabetes Mellitus, Type 2 - mortality | Treatment Failure | Cardiovascular Diseases - epidemiology | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide-1 Receptor - agonists | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Treatment outcome | Care and treatment | Analysis | Hypoglycemic agents | Dosage and administration | Acute coronary syndrome | Myocardial infarction | Cerebral infarction | Glucagon | Diabetes mellitus | Hypersensitivity | Pancreatitis | Angina | Glucose | Hypoglycemia | Morbidity | Studies | Heart rate | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Pancreas | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1 | Clinical trials | Regulatory approval | Hemoglobin | Drug dosages | Heart failure | Mortality
Journal Article